ADAR1 Capital Management »

Howard Hughes Holdings shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Howard Hughes Holdings (HHH) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Howard Hughes Holdings

Tip: Access up to 7 years of quarterly data

All positions including Howard Hughes Holdings held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Howard Hughes Holdings by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $73k 1.0k 72.62
2023-12-31 $257k 3.0k 85.55

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Howard Hughes Holdings

Pershing Square Capital Management
Vanguard Group
Dimensional Fund Advisors
Harris Associates L.P
Donald Smith & Co
BlackRock
BlackRock
Brandywine Global Investment Management
New South Capital Management
State Street Corporation
T. Rowe Price Investment Management
Dendur Capital
Geode Capital Management
Horizon Kinetics Asset Management
Jpmorgan Chase & Co

View all funds holding Howard Hughes Holdings